|
|
This slide is not for distribution in isolation and must be viewed in
conjunction with the accompanying term sheet, product supplement, underlying
supplement, prospectus supplement and prospectus, which further describe the
terms, conditions and risks associated with the notes.
Capped Contingent Buffered Equity Notes Linked to the FTSE[R] China A50 Index
due May 25, 2016
The notes are designed for investors who seek unleveraged exposure to the
appreciation of the FTSE[R] China A50 Index up to a maximum return that will
not be less than 16.00% at maturity. Investors should be willing to forgo
interest and dividend payments and, if the Ending Index Level is less than the
Initial Index Level by more than 25%, be willing to lose all of their principal
amount at maturity. Any payment on the notes is subject to the credit risk of
JPMorgan Chase and Co.
Trade Details/Characteristics
============================= ===================================================================================================================================================
Reference Index: The FTSE[R] China A50 Index (Bloomberg ticker: XIN9I) (the "Index")
Upside Leverage Factor: 1.0
Maximum Return: At least 16.00%.
For example, if the Index Return is equal to or greater than 16.00%, you will receive the Maximum Return of 16.00%, which entitles you
to a maximum payment at maturity of $1,160 per $1,000 principal amount note that you hold.
Contingent Buffer Amount: 25%
Index Return: (Ending Index Level -- Initial Index Level) / Initial Index Level
Initial Index Level: The Index closing level on the pricing date.
Ending Index Level The arithmetic average of the closing levels of the Index on each of the five Ending Average Dates.
Payment at Maturity: If the Ending Index Level is greater than the Initial Index Level, at maturity you will receive a cash payment that provides you with a
return per $1,000 principal amount note equal to the Index Return, subject to the Maximum Return. Accordingly, if the Ending Index
Level is greater than the Initial Index Level, your payment at maturity per $1,000 principal amount note will be calculated as follows:
$1,000 +($1,000 x Index Return), subject to the Maximum Return
If the Ending Index Level is equal to or less than the Initial Index Level by up to 25%, you will receive the principal amount of your notes
at maturity.
If the Ending Index Level is less than the Initial Index Level by more than 25%, you will lose 1% of the principal amount of your notes for
every 1% that the Ending Index Level is less than the Initial Index Level by more than 25%, and your payment at maturity per $1,000
principal amount note will be calculated as follows:
$1,000 + [$1,000 x (Index Return)]
If the Ending Index Level is less than the initial level by more than 25%, you will lose more than 25% of your principal amount and may lose all of
your principal amount at maturity.
Pricing Date: May 08, 2015
Ending Averaging Dates: May 16, 2016, May 17, 2016, May 18, 2016, May 19, 2016, and May 20, 2016 (the Final Ending Averaging
Date)
Preliminary Termsheet http://www.sec.gov/Archives/edgar/data/19617/000114036115017504/formfwp.htm
---------------------------------------------------------------------------------------------------------------------------------------------------
Please see the term sheet hyperlinked above for additional information about
the notes, including JPMS's estimated value, which is the estimated value of
the notes when the terms are set.
Risk Considerations
The risks identified below are not exhaustive. Please see the term sheet
hyperlinked above for more information.
[] Your investment in the notes may result in a loss.
[] The appreciation potential of the notes is limited, and you will not
participate in any appreciation in the Reference Index above the Maximum
Return.
[] Any payment on the notes is subject to the credit risk of JPMorgan Chase
and Co.
[] JPMorgan Chase and Co. and its affiliates play a variety of roles in
connection with the issuance of the notes, including acting as calculation
agent and hedging JPMorgan Chase and Co.'s obligations under the notes.
Their interests may be adverse to your interests.
[] The benefit provided by the contingent buffer may terminate on the final
Ending Average Date.
[] Lack of liquidity - J.P. Morgan Securities LLC ("JPMS") intends to offer
to purchase the notes in the secondary market but is not required to do
so. Even if there is a secondary market, it may not provide enough
liquidity to allow you to trade or sell the notes easily.
[] JPMS's estimated value does not represent the future value of the notes
and may differ from others' estimates.
[] JPMS's estimated value will be lower than the issue price (price to the
public) of the notes.
[] JPMS's estimated value is not determined by reference to credit spreads
for our conventional fixed rate debt.
[] Secondary market prices of the notes will likely be lower than the price
you paid for the notes and will be be impacted by many economic and market
factors.
[] No interest or divident payments or voting rights on the Index.
[] Risks related to non-U.S. issues of equity securities located in emerging
markets countries.
[] No direct exposure to fluctuations in foreign exchange rates; however,
currency fluctuations could affect the performance of the Index.
Hypothetical Return for the Notes at Maturity
[GRAPHIC OMITTED]
The following table illustrates the hypothetical total return at maturity on
the notes. The "total return" as used herein is the number, expressed as a
percentage, that results from comparing the payment at maturity per $1,000
principal amount note to $1,000.
Each hypothetical total return or hypothetical payment at maturity set forth
above and below assumes an Initial Index Level of 14,300 and a Maximum Return
of 16.00% .
The actual Maximum Return will be determined on the pricing date and will not
be less than 16.00% .
Hypothetical Examples of Amounts Payable at Maturity
Ending Index Level Index Return Total Return
================== ============ ============
25740.00 80.00% 16.00%
21450.00 50.00% 16.00%
20020.00 40.00% 16.00%
18590.00 30.00% 16.00%
16588.00 16.00% 16.00%
16016.00 12.00% 12.00%
15730.00 10.00% 10.00%
15015.00 5.00% 5.00%
14657.50 2.50% 2.50%
14300.00 0.00% 0.00%
13585.00 -5.00% 0.00%
12870.00 -10.00% 0.00%
11440.00 -20.00% 0.00%
10725.00 -25.00% 0.00%
10723.57 -25.01% -25.01%
5720.00 -60.00% -60.00%
1430.00 -90.00% -90.00%
0.00 -100.00% -100.00%
================== ============ ============
SEC Legend: JPMorgan Chase and Co. has filed a registration statement
(including a prospectus) with the SEC for any offerings to which these
materials relate. Before you invest, you should read the prospectus in that
registration statement and the other documents relating to this offering that
JPMorgan Chase and Co. has filed with the SEC for more complete information
about JPMorgan Chase and Co. and this offering. You may get these documents
without cost by visiting EDGAR on the SEC Web site at www.sec.gov.
Alternatively, JPMorgan Chase and Co., any agent or any dealer participating in
the this offering will arrange to send you the prospectus, the prospectus
supplement as well as any relevant product supplement, underlying supplement
and term sheet if you so request by calling toll-free 866-535-9248.
IRS Circular 230 Disclosure: JPMorgan Chase and Co. and its affiliates do not
provide tax advice. Accordingly, any discussion of U.S. tax matters contained
herein (including any attachments) is not intended or written to be used, and
cannot be used, in connection with the promotion, marketing or recommendation
by anyone unaffiliated with JPMorgan Chase and Co. of any of the matters
address herein or for the purpose of avoiding U.S. tax-related penalties.
Investment suitability must be determined individually for each investor, and
the financial instruments described herein may not be suitable for all
investors. This information is not intended to provide and should not be relied
upon as providing accounting, legal, regulatory or tax advice. Investors should
consult with their own advisors as to these matters.
This material is not a product of J.P. Morgan Research Departments. Filed
pursuant to Rule 433 Registration Statement No. 333-199966 Dated: May 05,2015
|